Chronic kidney disease and the gut microbiome

被引:196
|
作者
Hobby, Gerren P. [1 ]
Karaduta, Oleg [3 ]
Dusio, Giuseppina F. [1 ]
Singh, Manisha [1 ,2 ]
Zybailov, Boris L. [3 ]
Arthur, John M. [1 ,2 ]
机构
[1] Univ Arkansas Med Sci, Div Nephrol, Little Rock, AR 72211 USA
[2] Cent Arkansas Vet Hlth Syst, Little Rock, AR USA
[3] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72211 USA
关键词
chronic kidney disease; disease progression; gastrointestinal tract; indoxyl sulfate; metaproteomics; microbiome; P-CRESYL SULFATE; CHAIN FATTY-ACIDS; INDOXYL SULFATE; BIFIDOBACTERIUM; EPIDEMIOLOGY; ASSOCIATION; METABOLITES; DIVERSITY; FAILURE; SOLUTES;
D O I
10.1152/ajprenal.00298.2018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The gut microbiome is composed of a diverse population of bacteria that have beneficial and adverse effects on human health. The microbiome has recently gained attention and is increasingly noted to play a significant role in health and a number of disease states. Increasing urea concentration during chronic kidney disease (CKD) leads to alterations in the intestinal flora that can increase production of gut-derived toxins and alter the intestinal epithelial harrier. These changes can lead to an acceleration of the process of kidney injury. A number of strategies have been proposed to interrupt this pathway of injury in CKD. The purpose of this review is to summarize the role of the gut microbiome in CKD, tools used to study this microbial population, and attempts to alter its composition for therapeutic purposes.
引用
收藏
页码:F1211 / F1217
页数:7
相关论文
共 50 条
  • [21] The Role of the Gut Microbiome in Kidney Stone Disease
    Hanstock, Sarah
    Chew, Ben
    Lange, Dirk
    UROLOGIC CLINICS OF NORTH AMERICA, 2024, 51 (04) : 475 - 482
  • [22] Gut microbiome is unique in kidney stone disease
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (7) : 368 - 368
  • [23] The Gut Microbiome, Kidney Disease, and Targeted Interventions
    Ramezani, Ali
    Raj, Dominic S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (04): : 657 - 670
  • [24] Gut microbiome and kidney disease: a bidirectional relationship
    Souhaila Al Khodor
    Ibrahim F. Shatat
    Pediatric Nephrology, 2017, 32 : 921 - 931
  • [25] Gut microbiome and kidney disease: a bidirectional relationship
    Al Khodor, Souhaila
    Shatat, Ibrahim F.
    PEDIATRIC NEPHROLOGY, 2017, 32 (06) : 921 - 931
  • [26] Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity
    Wang, Haichao
    Ainiwaer, Aisima
    Song, Yaxiang
    Qin, Ling
    Peng, Ai
    Bao, Hui
    Qin, Huanlong
    MICROBIOME, 2023, 11 (01)
  • [27] Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity
    Haichao Wang
    Aisima Ainiwaer
    Yaxiang Song
    Ling Qin
    Ai Peng
    Hui Bao
    Huanlong Qin
    Microbiome, 11
  • [28] The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease
    Lau, Wei Ling
    Vaziri, Nosratola D.
    Nunes, Ane C. F.
    Comeau, Andre M.
    Langille, Morgan G., I
    England, Whitney
    Khazaeli, Mahyar
    Suematsu, Yasunori
    Phan, Joann
    Whiteson, Katrine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 367 (03): : 452 - 460
  • [29] ASSOCIATIONS BETWEEN URAEMIC TOXINS, SYMPTOMS AND THE GUT MICROBIOME IN ADVANCED CHRONIC KIDNEY DISEASE
    James, Philippa
    Dixit, Ojas
    Nicdao, Mary Ann
    Mcwhinney, Brett
    Stanford, Jordan
    Sud, Kamal
    Read, Scott
    Ahlenstiel, Golo
    Lambert, Kelly
    O'Brien, Claire
    Chau, Katrina
    NEPHROLOGY, 2022, 27 : 42 - 42
  • [30] Duodenal microbiome in chronic kidney disease
    Kondo, Masahiro
    Torisu, Takehiro
    Nagasue, Tomohiro
    Shibata, Hiroki
    Umeno, Junji
    Kawasaki, Keisuke
    Fujioka, Shin
    Matsuno, Yuichi
    Moriyama, Tomohiko
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (04) : 263 - 272